Psoriatic Arthritis News

Ustekinumab and TNF inhibitors demonstrate comparably persistent effects at 3 years in patients with psoriatic arthritis, but with fewer adverse events in those receiving ustekinumab, according to data.

Patients with psoriatic arthritis demonstrate a “substantial prevalence” of radiographic damage at baseline, which is related to time since diagnosis, according to data published in Arthritis Research and Therapy.

Risankizumab improves symptoms and is well tolerated through 52 weeks in patients with psoriatic arthritis who respond inadequately to biologic therapies or conventional synthetic disease-modifying antirheumatic drugs, according to data.

PHILADELPHIA — While a high prevalence of metabolic disorders was observed among patients with psoriatic arthritis, measures of disease activity was associated with adherence to healthy diet recommendations, such as low sugar and whole-fruit consumption.

PHILADELPHIA — Patients with psoriatic arthritis who achieved clinical disease control demonstrated clinically meaningful improvements across a broad range of patient-reported outcomes, including pain, fatigue, physical function and work productivity.

Adults with active psoriatic arthritis taking bimekizumab saw significant improvements in joint symptoms and skin clearance compared with those taking placebo, UCB announced in a press release.

PHILADELPHIA — Patients with psoriatic arthritis who have depression may perceive their disease differently compared with patients without depression which may make achievement of low disease activity or remission more challenging.

In 2021, Humira, the blockbuster biologic that has for years been the highest grossing drug in the world, accomplished something that no drug had previously achieved when its global revenues topped $20 billion.

PHILADELPHIA — While over half of referrals generated by results from a home-screening survey for psoriatic arthritis were deemed appropriate, the rate of an actual diagnosis was low, according to results of a study.

Understanding the mechanism of action by which psoriatic arthritis treatment works and taking a patient’s lifestyle into account can benefit clinicians treating patients with the condition, said Philip J. Mease, MD, of the Swedish Medical Center in Seattle and the University of Washington.